- Home
- ZURA vs MASS Comparison
ZURA vs MASS Comparison
Compare ZURA & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- MASS
- Stock Information
- Founded
- ZURA 2022
- MASS 2012
- Country
- ZURA United States
- MASS United States
- Employees
- ZURA N/A
- MASS N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- MASS Medical/Dental Instruments
- Sector
- ZURA Health Care
- MASS Health Care
- Exchange
- ZURA Nasdaq
- MASS Nasdaq
- Market Cap
- ZURA 76.6M
- MASS 84.3M
- IPO Year
- ZURA N/A
- MASS 2020
- Fundamental
- Price
- ZURA $1.21
- MASS $5.62
- Analyst Decision
- ZURA Buy
- MASS Buy
- Analyst Count
- ZURA 7
- MASS 3
- Target Price
- ZURA $14.33
- MASS $5.33
- AVG Volume (30 Days)
- ZURA 326.3K
- MASS 448.6K
- Earning Date
- ZURA 05-08-2025
- MASS 05-13-2025
- Dividend Yield
- ZURA N/A
- MASS N/A
- EPS Growth
- ZURA N/A
- MASS N/A
- EPS
- ZURA N/A
- MASS N/A
- Revenue
- ZURA N/A
- MASS $59,631,000.00
- Revenue This Year
- ZURA N/A
- MASS N/A
- Revenue Next Year
- ZURA N/A
- MASS $18.84
- P/E Ratio
- ZURA N/A
- MASS N/A
- Revenue Growth
- ZURA N/A
- MASS 18.72
- 52 Week Low
- ZURA $0.97
- MASS $1.81
- 52 Week High
- ZURA $6.35
- MASS $7.48
- Technical
- Relative Strength Index (RSI)
- ZURA 43.46
- MASS 62.56
- Support Level
- ZURA $1.17
- MASS $5.01
- Resistance Level
- ZURA $1.55
- MASS $5.93
- Average True Range (ATR)
- ZURA 0.14
- MASS 0.41
- MACD
- ZURA -0.02
- MASS -0.01
- Stochastic Oscillator
- ZURA 7.83
- MASS 70.64
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.